Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies' motion to amend its complaint in a lawsuit it filed against Twist Bioscience in 2016 was granted, according to documents Twist filed today with the US Securities and Exchange Commission.

The Santa Clara Superior Court also denied Agilent's motion to limit the discovery that Twist and Twist CEO Emily Leproust could seek in the case and set a date for the trial of Feb. 24, 2020.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.